Formosa Pharmaceuticals, Inc.

NT$21.00As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6838Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR (6.54%)
Div yield —
ROE (12.92%)
Biotechnology
Beta (5Y) 0.64
PE TTM —
TSR TTM (25.27%)
Mkt cap NT$3.171B
ROIC (7.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$22
6.92%
(34.11%)
Hold 6|1|6|3|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.38
0.40
0.41
0.44
22.48%
19.77%
17.93%
18.99%
RevenueNT$M
193.8
201.3
205.1
201.3
5.31%
12.10%
12.52%
6.45%
Peers (US$95.76M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.499
1.001
0.851
EBIT/Intx
1.407
0.506
0.384
Own earn%
190.83
(223.99)
(216.00)
Sh yield%
17.88
15.15
21.23
Owners
Insiders/Inst%
10.63
67.92
Short interest%
5.21
SBC / revenue%
3.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
14–24
$1 testx
0.1
Incr. ROIC%
11